View Single Post
Old 01-15-2011, 07:10 AM   #2
07rescue
Junior Member
 
Join Date: Dec 2008
Posts: 4
Re: LibiGel may be the first FDA approved product to treat HSDD in menopausal women

It's terrific news that there may be some help for HSDD in the general population, but there has been a general consensus among most oncologists that testosterone is contraindicated in breast cancer patients, especially we who have estrogen receptor positive tumors. I think we will need far more research into the use of testosterone before concluding that it will be safe for us to use. My doctors all have advised strongly against it, even with the concurrent use of an aromatase inhibitor to prevent conversion to estrogen.
07rescue is offline   Reply With Quote